Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
A 12-week clinical trial showed subjects taking AOD-9604 (1 mg/d) lost an average of 2.6 kg, compared to 0.8 kg in the placebo group.
Open Biology, 9 (8), 190126
Research evidence: Small human trials in glaucoma patients showed Cerebrolysin preserving visual field and retinal nerve fiber layer thickness better than control groups over 6-12 months
For research on musculoskeletal injuries (tendons, ligaments, muscles), the choice depends on the desired level of complexity: BPC-157 + TB-500 : The basic stack for regeneration angiogenesis + cell migration + anti-fibrosis
BPC-157s extensive publication record (100+ studies) provides the broadest preclinical safety dataset for either compound
Body Good welcomes eligible patients, but our brand, care model, and messaging are built especially for women navigating weight, hormones, metabolic health, and midlife changes.
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
US$ 23.20
US$ 26.05
US$ 20.02
